Prostate cancer trials in Spain
102 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Where
- Logrono, Madrid, Valencia
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07503808 · EU 2026-526299-21-00 - Phase 1/2Taking peopleFirst-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Where
- Barcelona, Logroño, Málaga
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07332455 - Phase 2Taking peopleA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Barakaldo, Córdoba, L'Hospitalet de Llobregat, Madrid, Valencia
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07287150 · EU 2025-521327-67-00 - Phase 3Taking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Jerez de la Frontera, Lugo, Madrid, Ourense, Sevilla, Valencia
- Age
- 18 years and over
- People
- 1,310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - Phase 3Taking peopleDiagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
- Where
- Barcelona, Valencia
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- ABX advanced biochemical compounds GmbH
See details and how to joinNCT06122584 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- L'Hospitalet de Llobregat, Madrid, Sevilla
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 1Enrolling by invitationA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Barcelona, Madrid, Pamplona, Salamanca
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - Phase 1Taking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - Phase 1Taking peopleA Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Where
- Barcelona, Madrid, Pamplona
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT05800665 · EU 2023-504013-68-00 - Phase 1Taking peopleA Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05818683 · EU 2022-503132-14-00 - Phase 3Taking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Barcelona, Jerez de la Frontera, Madrid, Málaga
- Age
- 18 years and over
- People
- 1,203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - Phase 3Taking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Badalona, Madrid, Murcia, Sevilla, Valencia, Zaragoza
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - Phase 1Taking peopleA Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Where
- Madrid
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07746713 · EU 2026-525894-37-00 - No phaseNot yet taking people in SpainAssessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
- Where
- Madrid
- People
- 50 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT07888322 - Phase 3Taking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- L'Hospitalet de Llobregat, Madrid, Valencia
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - Phase 3Taking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Barcelona, Córdoba, Lugo, Madrid, Majadahonda, Pozuelo de Alarcón, Santander, Santiago de Compostela, Sevilla, Valencia
- Age
- 18 years and over
- People
- 1,440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Barcelona, Logroño, Madrid, Palma, Zaragoza
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 1Taking peopleStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Age
- 18 years to 100 years
- People
- 272 worldwide
- Run by
- Janux Therapeutics
See details and how to joinNCT05519449 · EU 2026-526777-42-00 - Phase 1/2Taking peopleStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 205 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07288359 - Phase 1Taking peopleSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Where
- Barcelona, Logrono, Madrid, Málaga, Murcia, Pamplona, Pozuelo de Alarcón, Sabadell, Valencia
- Age
- 18 years and over
- People
- 347 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05997615 · EU 2023-503495-24-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1Taking peopleA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07244341 · EU 2025-522512-16-00 - Phase 1Taking peopleA clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
- Where
- Madrid, Valencia
- Age
- 18 years and over
- People
- 26 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-524080-20-00 · EU 2025-524080-20-00 - Phase 1Taking peopleA Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Where
- Madrid, Valencia
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07570979 - Phase 1/2Taking peopleStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santander, Valencia
- Age
- 18 years to 130 years
- People
- 283 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07181161 · EU 2024-520026-11-00